Browse by Journal Title

Article

DOTAM-based, targeted, activatable fluorescent probes for the highly sensitive and selective detection of cancer cells.
Brennecke, B. and Wang, Q. and Haap, W. and Grether, U. and Hu, H.Y. and Nazaré, M.
Bioconjugate Chemistry 32 (4): 702-712. 21 April 2021

In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3.
Ryppa, C. and Mann-Steinberg, H. and Fichtner, I. and Weber, H. and Satchi-Fainaro, R. and Biniossek, M.L. and Kratz, F.
Bioconjugate Chemistry 19 (7): 1414-1422. July 2008

Development of albumin-binding camptothecin prodrugs using a peptide positional scanning library.
Schmid, B. and Warnecke, A. and Fichtner, I. and Jung, M. and Kratz, F.
Bioconjugate Chemistry 18 (6): 1786-1799. November 2007

Albumin-Binding Prodrugs of Camptothecin and Doxorubicin with an Ala-Leu-Ala-Leu-Linker That Are Cleaved by Cathepsin B: Synthesis and Antitumor Efficacy.
Schmid, B. and Chung, D.E. and Warnecke, A. and Fichtner, I. and Kratz, F.
Bioconjugate Chemistry 18 (3): 702-716. May 2007

Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug Carboplatin designed as albumin-binding prodrugs.
Warnecke, A. and Fichtner, I. and Garmann, D. and Jaehde, U. and Kratz, F.
Bioconjugate Chemistry 15 (6): 1349-1359. 1 November 2004